Ravi Salgia
Impact in
- Hepatology top 0.2%
- Liver physiology and pathology
- Oncology top 0.05%
- Lung Cancer Research Studies
Papers in
- Oncology 286
- Lung Cancer Research Studies 103
- Colorectal Cancer Treatments and Studies 51
-
- PI3K/AKT/mTOR signaling in cancer 61
- Cancer therapeutics and mechanisms 40
- Co-authors
- Martin Sattler (62 shared papers)James D. Griffin (38 shared papers)C. Patrick (18 shared papers)Gautam Maulik (15 shared papers)Jun Gong (8 shared papers)James G. Christensen (12 shared papers)Alex Chehrazi‐Raffle (2 shared papers)Evan Pisick (24 shared papers)
- Journals
- Journal of Clinical Oncology (76 papers)Journal of Biological Chemistry (27 papers)Cancer Research (21 papers)Journal of Thoracic Oncology (19 papers)Journal of Clinical Medicine (18 papers)
- Partner nations
- United StatesIndiaSouth Korea
In The Last Decade
Ravi Salgia
610 papers receiving 27.0k citations
Ravi Salgia's Hit Papers
Peers
Comparison fields: 5 of 178
- Hepatology 3.2k
- Oncology 10.6k
- Pulmonary and Respiratory Medicine 8.4k
- Cancer Research 3.7k
- Immunology and Allergy 1.4k
Countries citing papers authored by Ravi Salgia
This map shows the geographic impact of Ravi Salgia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Salgia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Salgia more than expected).
Fields of papers citing papers by Ravi Salgia
This network shows the impact of papers produced by Ravi Salgia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Salgia. The network helps show where Ravi Salgia may publish in the future.
Co-authors
The 25 scholars most cited alongside Ravi Salgia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 626 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations Hit paper breakdown → | 2018 | 969 |
| 2 | 2012 | 477 | |
| 3 | 2005 | 467 | |
| 4 | The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups Hit paper breakdown → | 2012 | 464 |
| 5 | Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer Hit paper breakdown → | 2011 | 445 |
| 6 | 2004 | 424 | |
| 7 | 2003 | 408 | |
| 8 | c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. | 2003 | 370 |
| 9 | 2011 | 353 | |
| 10 | 2011 | 337 | |
| 11 | 2002 | 327 | |
| 12 | 2004 | 282 | |
| 13 | 2016 | 261 | |
| 14 | 2000 | 260 | |
| 15 | 2011 | 246 | |
| 16 | 1995 | 246 | |
| 17 | 2008 | 245 | |
| 18 | Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. | 2002 | 234 |
| 19 | The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. | 1996 | 228 |
| 20 | 2007 | 216 |
About Ravi Salgia
Ravi Salgia is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Hepatology, having authored 626 papers that have together received 27.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (199 papers), Lung Cancer Research Studies (103 papers), Liver physiology and pathology (68 papers), PI3K/AKT/mTOR signaling in cancer (61 papers), Lung Cancer Diagnosis and Treatment (59 papers), Colorectal Cancer Treatments and Studies (51 papers), Cancer Genomics and Diagnostics (49 papers) and Cancer therapeutics and mechanisms (40 papers). The work is most often cited by research in Hepatology (3.2k citations), Oncology (10.6k citations), Pulmonary and Respiratory Medicine (8.4k citations), Cancer Research (3.7k citations) and Immunology and Allergy (1.4k citations). Ravi Salgia has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include Martin Sattler, James D. Griffin, C. Patrick, Gautam Maulik, Jun Gong, James G. Christensen, Alex Chehrazi‐Raffle, Evan Pisick, Aliya N. Husain and Everett E. Vokes. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry, Cancer Research, Journal of Thoracic Oncology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.